‘Greed, greed, greed’: Sanders demands Ozempic maker lower prices
While grilling Novo Nordisk’s chief executive over the price of its blockbuster diabetes and weight-loss drugs, Ozempic and Wegovy, on Tuesday, Sen. Bernie Sanders alleged that 40,000 people a year in the US could die if the company doesn’t make the medicines more affordable.
The health benefits of blockbuster weight loss drugs are bridging the stark political divide in the United States.
Novo Nordisk charges $969 per month for Ozempic in the U.S., compared ... they don't understand what happens with pricing a ...
Novo Nordisk’s blockbuster type 2 diabetes medication is a sure bet for the list of the next 15 drugs whose Medicare prices ...
Hidradenitis suppurativa is a lesion-causing inflammatory disorder that affects at least 1 in 100 people and is strongly ...
A committee report found the weight loss drug is offered for less than $100 in some European countries, compared to monthly ...
Novo Nordisk's blockbuster diabetes drug Ozempic will be eligible for U.S. government's price negotiations in less than a ...
Sen. Bernie Sanders grilled the CEO of Novo Nordisk, the maker of Ozempic, over the price of the breakthrough diabetes and weight loss drug.
WASHINGTON—U.S. Senator Mike Braun questioned Novo Nordisk CEO, Lars Fruergaard Jørgensen, at the Senate Health, Education, ...
An Australian celebrity was reportedly overheard telling others at a party how they allegedly got their hands on Ozempic to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback